Clinical Trials Browser

pexidartinib × Dermatologic × Clear all

NCT02975700 2026-01-13

A Study of PLX3397 in Patients With Unresectable or Metastatic KIT-mutated Melanoma

Phase NA Completed

6 enrolled 21 charts

Melanoma

NCT02071940 2021-08-12

PIANO

Phase 2 Completed

Melanoma